Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,286 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Anifrolumab in Refractory Systemic Lupus Erythematosus: A Real-World, Multicenter Study.
Tani C, Cardelli C, Zen M, Moroni L, Piga M, Ceccarelli F, Fasano S, De Marchi G, Coladonato L, Emmi G, Gatto M, Trentin F, Ramirez GA, Chessa E, Gallina G, Picciariello L, Patrone M, Urban ML, Biancalana E, Quartuccio L, Ciccia F, Conti F, Cauli A, Dagna L, Doria A, Mosca M. Tani C, et al. Among authors: doria a. J Rheumatol. 2024 Aug 15:jrheum.2024-0053. doi: 10.3899/jrheum.2024-0053. Online ahead of print. J Rheumatol. 2024. PMID: 38950957
Long-term outcomes of COVID-19 vaccination in patients with rare and complex connective tissue diseases: The ERN-ReCONNET VACCINATE study.
Tani C, Cardelli C, Depascale R, Gamba A, Iaccarino L, Doria A, Bandeira M, Dinis SP, Romão VC, Gotelli E, Paolino S, Cutolo M, Di Giosaffatte N, Ferraris A, Grammatico P, Cavagna L, Codullo V, Montecucco C, Longo V, Beretta L, Cavazzana I, Fredi M, Peretti S, Guiducci S, Matucci-Cerinic M, Bombardieri S, Burmester GR, Fonseca JE, Frank C, Galetti I, Hachulla E, Müller-Ladner U, Schneider M, Smith V, Tamirou F, Van Laar JM, Vieira A, D'Urzo R, Cannizzo S, Gaglioti A, Marinello D, Talarico R, Mosca M. Tani C, et al. Among authors: doria a. J Transl Autoimmun. 2023 Nov 28;7:100221. doi: 10.1016/j.jtauto.2023.100221. eCollection 2023 Dec. J Transl Autoimmun. 2023. PMID: 38162456 Free PMC article.
Practice pattern for the use of intravenous iloprost for the treatment of peripheral vasculopathy in systemic sclerosis: A case-control study from the Italian national multicenter "SPRING" (Systemic Sclerosis Progression InvestiGation) Registry.
Riccieri V, Pellegrino G, Cipolletta E, Giuggioli D, Bajocchi G, Bellando-Randone S, Dagna L, Zanframundo G, Foti R, Cacciapaglia F, Cuomo G, Ariani A, Rosato E, Lepri G, Girelli F, Zanatta E, Bosello SL, Cavazzana I, Ingegnoli F, De Santis M, Murdaca G, Abignano G, Romeo N, Della Rossa A, Caminiti M, Iuliano A, Ciano G, Beretta L, Bagnato G, Lubrano E, De Andres I, Giollo A, Saracco M, Agnes C, Lumetti F, Spinella A, Magnani L, Campochiaro C, De Luca G, Codullo V, Visalli E, Di Vico C, Gigante A, Saccon F, Grazia Lazzaroni M, Franceschini F, Generali E, Mennillo G, Barsotti S, Pagano Mariano G, Calabrese F, Furini F, Vultaggio L, Parisi S, Peroni CL, Bianchi G, Conti F, Cozzi F, D'Angelo S, Doria A, Fusaro E, Govoni M, Guiducci S, Iannone F, Salvarani C, Sebastiani GD, Ferri C, Matucci-Cerinic M, De Angelis R. Riccieri V, et al. Among authors: doria a. J Scleroderma Relat Disord. 2024 Feb;9(1):38-49. doi: 10.1177/23971983231209809. Epub 2024 Jan 11. J Scleroderma Relat Disord. 2024. PMID: 38333531
Therapeutic strategies and outcomes in neuropsychiatric systemic lupus erythematosus: an international multicentre retrospective study.
Bortoluzzi A, Fanouriakis A, Silvagni E, Appenzeller S, Carli L, Carrara G, Cauli A, Conti F, Costallat LTL, De Marchi G, Doria A, Fredi M, Franceschini F, Garaffoni C, Hanly JG, Mosca M, Murphy E, Piga M, Quartuccio L, Scirè CA, Tomietto P, Truglia S, Zanetti A, Zen M, Bertsias G, Govoni M. Bortoluzzi A, et al. Among authors: doria a. Rheumatology (Oxford). 2024 Oct 1;63(10):2711-2720. doi: 10.1093/rheumatology/keae119. Rheumatology (Oxford). 2024. PMID: 38402539
Tailoring the treatment of inflammatory rheumatic diseases by a better stratification and characterization of the clinical patient heterogeneity. Findings from a systematic literature review and experts' consensus.
Ruscitti P, Allanore Y, Baldini C, Barilaro G, Bartoloni Bocci E, Bearzi P, Bellis E, Berardicurti O, Biaggi A, Bombardieri M, Cantarini L, Cantatore FP, Caporali R, Caso F, Cervera R, Ciccia F, Cipriani P, Chatzis L, Colafrancesco S, Conti F, Corberi E, Costa L, Currado D, Cutolo M, D'Angelo S, Del Galdo F, Di Cola I, Di Donato S, Distler O, D'Onofrio B, Doria A, Fautrel B, Fasano S, Feist E, Fisher BA, Gabini M, Gandolfo S, Gatto M, Genovali I, Gerli R, Grembiale RD, Guggino G, Hoffmann-Vold AM, Iagnocco A, Iaquinta FS, Liakouli V, Manoussakis MN, Marino A, Mauro D, Montecucco C, Mosca M, Naty S, Navarini L, Occhialini D, Orefice V, Perosa F, Perricone C, Pilato A, Pitzalis C, Pontarini E, Prete M, Priori R, Rivellese F, Sarzi-Puttini P, Scarpa R, Sebastiani G, Selmi C, Shoenfeld Y, Triolo G, Trunfio F, Yan Q, Tzioufas AG, Giacomelli R. Ruscitti P, et al. Among authors: doria a. Autoimmun Rev. 2024 Jul-Aug;23(7-8):103581. doi: 10.1016/j.autrev.2024.103581. Epub 2024 Jul 26. Autoimmun Rev. 2024. PMID: 39069240
Effectiveness and safety of low dose Rituximab as remission-maintenance treatment for patients with refractory idiopathic inflammatory myopathies: results of a retrospective study from a monocentric cohort.
Gamba A, Depascale R, Zanatta E, Ienna L, Cruciani C, Gatto M, Zen M, Doria A, Iaccarino L. Gamba A, et al. Among authors: doria a. Clin Rheumatol. 2024 Oct;43(10):3167-3174. doi: 10.1007/s10067-024-07079-z. Epub 2024 Aug 28. Clin Rheumatol. 2024. PMID: 39196499 Free PMC article.
Preferences for diagnostic pathways and treatment choice in systemic lupus erythematosus: a patient-based discrete choice experiment.
Quartuccio L, Piga M, Atzeni F, Callori M, Doria A, Emmi G, Franceschini F, Gerosa M, Mosca M, Pasqualetti P, Pelissero R, Sebastiani GD, Conti F, Govoni M. Quartuccio L, et al. Among authors: doria a. Clin Exp Rheumatol. 2024 Sep 10. doi: 10.55563/clinexprheumatol/clx4p7. Online ahead of print. Clin Exp Rheumatol. 2024. PMID: 39263793
Four-year effectiveness, safety and drug retention rate of secukinumab in psoriatic arthritis: a real-life Italian multicenter cohort.
Ramonda R, Lorenzin M, Chimenti MS, Atzeni F, Semeraro A, D'Angelo S, Selmi C, Ortolan A, Marchesoni A, Manara M, Luchetti Gentiloni MM, Santo L, Salvarani C, Cauli A, Rossini M, Amato G, Cozzi G, Scagnellato L, Ferraioli M, Carriero A, Fracassi E, Giorgio F, Doria A, Foti R, Carletto A; on behalf Spondyloarthritis and Psoriatic Arthritis SIR Study Group “Antonio Spadaro”. Ramonda R, et al. Among authors: doria a. Arthritis Res Ther. 2024 Sep 28;26(1):172. doi: 10.1186/s13075-024-03401-x. Arthritis Res Ther. 2024. PMID: 39342310 Free PMC article.
1,286 results